MX2014001282A - Oxazolidinona que contiene compuestos de dimero, composicones y metodos para elaborar y usar. - Google Patents

Oxazolidinona que contiene compuestos de dimero, composicones y metodos para elaborar y usar.

Info

Publication number
MX2014001282A
MX2014001282A MX2014001282A MX2014001282A MX2014001282A MX 2014001282 A MX2014001282 A MX 2014001282A MX 2014001282 A MX2014001282 A MX 2014001282A MX 2014001282 A MX2014001282 A MX 2014001282A MX 2014001282 A MX2014001282 A MX 2014001282A
Authority
MX
Mexico
Prior art keywords
methods
compositions
make
oxazolidinone
compound
Prior art date
Application number
MX2014001282A
Other languages
English (en)
Inventor
John Finn
D Keith Hester
Robert J Duguid
Original Assignee
Trius Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trius Therapeutics Inc filed Critical Trius Therapeutics Inc
Publication of MX2014001282A publication Critical patent/MX2014001282A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Abstract

Formas de dosificación o composiciones farmacéuticas que comprenden un compuesto con la estructura de fórmula IV: (ver Fórmula) en donde n es un entero no negativo; en donde cada Z es una región que contiene oxazolidinona con actividad antibiótica in vivo al clivaje, en donde M es independientemente OR1 o NR1R2 en donde R1 y R2 son independientemente seleccionados del grupo que consiste de H, residuo hidrocarbilo opcionalmente sustituido o un catión farmacéuticamente aceptable; en donde el compuesto en la forma de dosificación o una composición farmacéutica está presente en una cantidad efectiva para el tratamiento o prevención de una infección antibacterial en un sujeto mamífero. Métodos de preparación y uso de las formas de dosificación o composiciones farmacéuticas también se describen.
MX2014001282A 2009-05-28 2014-01-30 Oxazolidinona que contiene compuestos de dimero, composicones y metodos para elaborar y usar. MX2014001282A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18195509P 2009-05-28 2009-05-28
US12/787,293 US8580767B2 (en) 2009-05-28 2010-05-25 Oxazolidinone containing dimer compounds, compositions and methods to make and use

Publications (1)

Publication Number Publication Date
MX2014001282A true MX2014001282A (es) 2014-06-10

Family

ID=42333294

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2011012544A MX2011012544A (es) 2009-05-28 2010-05-27 Oxazolidinona que contiene compuestos de dimero, composiciones y metodos para elaborar y usar.
MX2014001282A MX2014001282A (es) 2009-05-28 2014-01-30 Oxazolidinona que contiene compuestos de dimero, composicones y metodos para elaborar y usar.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2011012544A MX2011012544A (es) 2009-05-28 2010-05-27 Oxazolidinona que contiene compuestos de dimero, composiciones y metodos para elaborar y usar.

Country Status (13)

Country Link
US (2) US8580767B2 (es)
EP (1) EP2435051A1 (es)
JP (2) JP5785939B2 (es)
KR (1) KR101745511B1 (es)
CN (2) CN103923122B (es)
AU (1) AU2010254039B2 (es)
BR (1) BRPI1012047A2 (es)
CA (1) CA2769769A1 (es)
IL (2) IL216547A0 (es)
MX (2) MX2011012544A (es)
NZ (2) NZ620552A (es)
RU (2) RU2557910C2 (es)
WO (1) WO2010138649A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
CN106220621B (zh) 2008-10-10 2019-06-11 默沙东公司 制备噁唑烷酮类的方法及含有噁唑烷酮类的组合物
NZ594408A (en) 2009-02-03 2014-03-28 Trius Therapeutics Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
US8580767B2 (en) 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
CN105229001B (zh) * 2014-04-18 2017-04-26 杭州普晒医药科技有限公司 一种噁唑烷酮类抗生素的晶型及制备方法、组合物和用途
WO2016063246A1 (en) * 2014-10-22 2016-04-28 Sun Pharmaceutical Industries Limited Crystalline form r of tedizolid phosphate
WO2019118311A1 (en) 2017-12-13 2019-06-20 Merck Sharp & Dohme Corp. Pharmaceutical compositions of tedizolid phosphate
CN111825666B (zh) * 2019-04-23 2024-03-08 上海仕谱生物科技有限公司 二聚或多聚体形式的突变型idh抑制剂
US20230219941A1 (en) 2020-06-18 2023-07-13 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU80081A1 (fr) * 1977-08-26 1979-05-15 Delalande Sa Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
US4128654A (en) * 1978-02-10 1978-12-05 E. I. Du Pont De Nemours And Company 5-Halomethyl-3-phenyl-2-oxazolidinones
US4340606A (en) 1980-10-23 1982-07-20 E. I. Du Pont De Nemours And Company 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
FR2500450A1 (fr) * 1981-02-25 1982-08-27 Delalande Sa Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
US4461773A (en) * 1982-09-15 1984-07-24 E. I. Dupont De Nemours And Company P-Oxooxazolidinylbenzene compounds as antibacterial agents
CA1320730C (en) 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
EP0610265B1 (en) 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
SK283420B6 (sk) 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
DE69316240T2 (de) * 1992-12-08 1998-05-20 Upjohn Co Durch eine tropon gruppe substituierte phenyloxazolidinone-derivate als antibakterielles mittel
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
JP3698724B2 (ja) 1993-11-22 2005-09-21 ファルマシア・アンド・アップジョン・カンパニー 置換−ヒドロキシアセチルピペラジンフェニルオキサゾリジノンのエステル
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
BR0111280A (pt) * 2000-06-05 2003-06-10 Dong A Pharm Co Ltd Novos derivados de oxazolidinona e um processo para a preparação dos mesmos
US20020115669A1 (en) * 2000-08-31 2002-08-22 Wiedeman Paul E. Oxazolidinone chemotherapeutic agents
DE60212959T2 (de) 2001-04-07 2007-02-15 Astrazeneca Ab Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika
US6627646B2 (en) 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs
PT1427711E (pt) 2001-09-11 2005-11-30 Astrazeneca Ab Derivados de oxazolidinona e/ou isoxazolina como agentes antibacterianos
JP2005519870A (ja) 2001-10-25 2005-07-07 アストラゼネカ アクチボラグ 抗菌活性をもつアリール置換オキサゾリジノン類
NZ515881A (en) 2001-12-03 2004-09-24 New Zealand Dairy Board Cheese flavour ingredient and method of its production
IL163688A0 (en) * 2002-02-28 2005-12-18 Astrazeneca Ab 3-Cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and theiruse as antibacterial agents
CA2477379A1 (en) 2002-02-28 2003-09-04 Astrazeneca Ab Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
EP1581524A2 (en) 2002-11-28 2005-10-05 AstraZeneca AB Oxazolidinones as antibacterial agents
US20060116400A1 (en) * 2002-11-28 2006-06-01 Astrazeneca Ab Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
US7144911B2 (en) * 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7202257B2 (en) * 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
TW200500360A (en) * 2003-03-01 2005-01-01 Astrazeneca Ab Hydroxymethyl compounds
GB0306358D0 (en) 2003-03-20 2003-04-23 Astrazeneca Ab Chemical compounds
EP1654259A1 (en) * 2003-07-02 2006-05-10 Merck & Co., Inc. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
CA2530140C (en) * 2003-07-02 2010-11-09 Merck & Co., Inc. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
WO2005051933A1 (en) 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited An improved process for the synthesis of 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylic acid tert-butyl ester, a key intermediate for oxazolidinone antimicrobials and compounds prepared thereby
EP1713785A1 (en) * 2003-12-17 2006-10-25 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
US20070191336A1 (en) * 2003-12-24 2007-08-16 Flynn Daniel L Anti-inflammatory medicaments
GB0411596D0 (en) 2004-05-25 2004-06-30 Astrazeneca Ab Chemical process
JP2008500317A (ja) * 2004-05-25 2008-01-10 アストラゼネカ アクチボラグ 抗菌剤としての３−’４−｛６−置換アルカノイル）ピリジン−３−イル｝−３−フェニル−５−（１ｈ−１，２，３−トリアゾール−１−イルメチル）−１，３−オキサゾリジン−２−オン
JP2008500319A (ja) * 2004-05-25 2008-01-10 アストラゼネカ アクチボラグ 細菌感染症の治療のためのｍａｏ阻害剤としての３−（４−（２−ジヒドロイソオキサゾール−３−イルピリジン−５−イル）フェニル−５−トリアゾール−１−イルメチルオキサゾリジン−２−オン誘導体
US20080021071A1 (en) * 2004-05-25 2008-01-24 Astrazeneca Ab 3-{4-(Pyridin-3-Yl) Phenyl}-5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents
US20080064689A1 (en) * 2004-05-25 2008-03-13 Astrazeneca Ab 3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents
US20100286211A1 (en) 2004-10-08 2010-11-11 Biswajit Das Oxazolidinone derivatives as antimicrobials
US20090018123A1 (en) * 2005-06-20 2009-01-15 Milind D Sindkhedkar Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation
WO2007138381A2 (en) 2005-10-14 2007-12-06 Targanta Therapeutics Inc. Phosphonated oxazolidinones and uses thereof for the prevention and treatment of bone and joint infections
CA2695616C (en) * 2007-08-06 2015-11-24 Micurx Pharmaceuticals, Inc. Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
CN106220621B (zh) 2008-10-10 2019-06-11 默沙东公司 制备噁唑烷酮类的方法及含有噁唑烷酮类的组合物
NZ594408A (en) * 2009-02-03 2014-03-28 Trius Therapeutics Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
US8580767B2 (en) 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use

Also Published As

Publication number Publication date
MX2011012544A (es) 2012-02-28
RU2557910C2 (ru) 2015-07-27
BRPI1012047A2 (pt) 2019-09-24
JP2016026145A (ja) 2016-02-12
AU2010254039A1 (en) 2011-12-15
NZ596602A (en) 2014-02-28
KR101745511B1 (ko) 2017-06-20
EP2435051A1 (en) 2012-04-04
IL239049A0 (en) 2015-07-30
RU2015122032A (ru) 2015-12-10
CN103923122B (zh) 2016-08-24
CN102497866B (zh) 2014-09-17
NZ620552A (en) 2015-08-28
US8580767B2 (en) 2013-11-12
AU2010254039B2 (en) 2016-03-03
JP2012528182A (ja) 2012-11-12
IL239049A (en) 2017-07-31
US20140057874A1 (en) 2014-02-27
CN103923122A (zh) 2014-07-16
IL216547A0 (en) 2012-02-29
JP6010196B2 (ja) 2016-10-19
CA2769769A1 (en) 2010-12-02
CN102497866A (zh) 2012-06-13
KR20120026568A (ko) 2012-03-19
WO2010138649A1 (en) 2010-12-02
JP5785939B2 (ja) 2015-09-30
US20100305069A1 (en) 2010-12-02

Similar Documents

Publication Publication Date Title
MX2014001282A (es) Oxazolidinona que contiene compuestos de dimero, composicones y metodos para elaborar y usar.
AU2016202535B2 (en) Fused heterocyclic compounds as sodium channel modulators
MX2010005632A (es) Analogos de aminoglucosidos antibacterianos.
MY183588A (en) New salvianolic acid compound l, preparation method and use thereof
BR112013011580A2 (pt) derivados de ácido bisfenil pentanoico substituído por amino como inibidores de nep
BR112013003045A2 (pt) composto e composição farmacêutica e respectivos usos, recipiente estéril e método para preparar composição farmacêutica para administração
CO6470846A2 (es) Derivados aminobut´ricos sustituidos como inhibidores de neprilisina
BR112013013950A2 (pt) antagonista de lpa1 policíclico e usos dos mesmos
PH12014502524A1 (en) Carboxylic acid compounds
CU20110217A7 (es) Derivados amino-propiónicos sustituidos como inhibidores de neprilisina
TN2012000413A1 (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
MY149731A (en) Compounds
MY191829A (en) Certain amino-pyridazines, compositions thereof, and methods of their use
UA110013C2 (uk) Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів
GB2454615A (en) Antidiabetic azabicyclo (3.1.0) hexan compounds
BR112012023178A2 (pt) ramidinas substituídas como antagonistas de receptor prostaglandina 2
MX2011013648A (es) Nuevos compuestos, composiciones farmaceuticas y metodos relacionados con ellos.
NZ734152A (en) Compounds, compositions and methods useful for cholesterol mobilisation
MX2013000474A (es) Derivados de arilamida novedosos que tienen propiedades antiandrogenicas.
MX2011009709A (es) Compuestos para el tratamiento de la inflamacion y del dolor.
GEP20125548B (en) New dihidroindolone compounds, a process for its preparation and pharmaceutical compositions containing them
MX2012014918A (es) Compuestos y metodos para tratamiento o prevencion de infecciones por flavivirus.
EA201190234A1 (ru) Новые амидные производные стероидных соединений [3,2-c]пиразолов с глюкокортикоидной активностью
TW200635600A (en) Tetracyclic bicyclolides
BR112012006233B8 (pt) composto de fórmula i, composição farmacêutica e usos de um composto